In:
Dermatology, S. Karger AG, Vol. 213, No. 2 ( 2006), p. 134-139
Abstract:
〈 i 〉 Background: 〈 /i 〉 The excimer laser is a new therapeutic option in the treatment of psoriasis vulgaris. 〈 i 〉 Objective: 〈 /i 〉 The purpose of this study was to determine the response of psoriasis lesions to the 308-nm excimer laser compared to 311-nm UVB phototherapy. 〈 i 〉 Methods: 〈 /i 〉 In this prospective right/left comparative, open, single-blinded trial, selected psoriasis plaques of 16 patients were treated with the excimer laser whereas the rest of the body was treated with UVB narrow-band phototherapy. A modified PASI score was used to evaluate the results. 〈 i 〉 Results: 〈 /i 〉 After 12 treatments, 15 patients were evaluated. In 2 patients no difference between the two body sides was observed. In 9 patients the laser-treated lesions showed better results, whereas in 4 patients the side treated with 311-nm UVB showed more clearing. The mean reduction in PASI score was 5.6 and 4.9, respectively (difference not significant). 〈 i 〉 Conclusion: 〈 /i 〉 The use of the 308-nm xenon chloride excimer laser is an additional effective therapeutic option for the treatment of psoriasis vulgaris.
Type of Medium:
Online Resource
ISSN:
1018-8665
,
1421-9832
Language:
English
Publisher:
S. Karger AG
Publication Date:
2006
detail.hit.zdb_id:
1482189-8
Bookmarklink